Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    October 2018
  1. SHIMIZU M, Tanaka N
    IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0533.
    PubMed     Text format     Abstract available


    September 2018
  2. YU W, Ding J, He M, Chen Y, et al
    Estrogen receptor beta promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0463.
    PubMed     Text format     Abstract available


  3. LIN YP, Wu JI, Tseng CW, Chen HJ, et al
    Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0471.
    PubMed     Text format     Abstract available


    August 2018
  4. LIANG SQ, Buhrer ED, Berezowska S, Marti TM, et al
    mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0479.
    PubMed     Text format     Abstract available


  5. YOCHUM ZA, Cades J, Wang H, Chatterjee S, et al
    Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0482.
    PubMed     Text format     Abstract available


  6. KIM IK, McCutcheon JN, Rao G, Liu SV, et al
    Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0429.
    PubMed     Text format     Abstract available


    July 2018
  7. LU CH, Yeh DW, Lai CY, Liu YL, et al
    USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0411.
    PubMed     Text format     Abstract available


    June 2018
  8. WANG K, Ji W, Yu Y, Li Z, et al
    FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0311.
    PubMed     Text format     Abstract available


    May 2018
  9. JI X, Qian J, Rahman SMJ, Siska PJ, et al
    xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
    Oncogene. 2018 May 23. pii: 10.1038/s41388-018-0307.
    PubMed     Text format     Abstract available


  10. ZHAO C, Li Y, Qiu W, He F, et al
    C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0298.
    PubMed     Text format     Abstract available


    April 2018
  11. WANG S, Jia M, He Z, Liu XS, et al
    APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
    Oncogene. 2018 Apr 26. pii: 10.1038/s41388-018-0245.
    PubMed     Text format     Abstract available


  12. TOMOSHIGE K, Guo M, Tsuchiya T, Fukazawa T, et al
    An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0240.
    PubMed     Text format     Abstract available


  13. NEWMAN JH, Augeri DJ, NeMoyer R, Malhotra J, et al
    Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0156.
    PubMed     Text format     Abstract available


  14. PENTIMALLI F, Forte IM, Esposito L, Indovina P, et al
    RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
    Oncogene. 2018 Apr 2. pii: 10.1038/s41388-018-0214.
    PubMed     Text format     Abstract available


    March 2018
  15. MONTERISI S, Riso PL, Russo K, Bertalot G, et al
    HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.
    Oncogene. 2018 Mar 26. pii: 10.1038/s41388-018-0229.
    PubMed     Text format     Abstract available


  16. MEDER L, Konig K, Dietlein F, Macheleidt I, et al
    LIN28B enhanced tumorigenesis in an autochthonous KRAS(G12V)-driven lung carcinoma mouse model.
    Oncogene. 2018 Mar 5. pii: 10.1038/s41388-018-0158.
    PubMed     Text format     Abstract available


    February 2018
  17. LAI Q, Wang H, Li A, Xu Y, et al
    Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells.
    Oncogene. 2018 Feb 9. pii: 10.1038/s41388-018-0125.
    PubMed     Text format     Abstract available


    January 2018
  18. ZHENG X, Chi J, Zhi J, Zhang H, et al
    Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
    Oncogene. 2018;37:502-511.
    PubMed     Text format     Abstract available


  19. WELCKER D, Jain M, Khurshid S, Jokic M, et al
    AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0054.
    PubMed     Text format     Abstract available


  20. CORKERY DP, Clarke LE, Gebremeskel S, Salsman J, et al
    Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
    Oncogene. 2018;37:174-184.
    PubMed     Text format     Abstract available


    November 2017
  21. SZYMICZEK A, Carbone M, Pastorino S, Napolitano A, et al
    Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.
    Oncogene. 2017;36:6501-6507.
    PubMed     Text format     Abstract available


  22. ZHONG Y, Yang J, Xu WW, Wang Y, et al
    KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
    Oncogene. 2017;36:6177-6189.
    PubMed     Text format     Abstract available


  23. TORRENTE L, Sanchez C, Moreno R, Chowdhry S, et al
    Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.
    Oncogene. 2017;36:6204-6212.
    PubMed     Text format     Abstract available


  24. TRINIDAD AG, Whalley N, Rowlinson R, Delpuech O, et al
    Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells.
    Oncogene. 2017;36:6164-6176.
    PubMed     Text format     Abstract available


    October 2017
  25. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Text format     Abstract available


  26. IVANOV AA, Gonzalez-Pecchi V, Khuri LF, Niu Q, et al
    OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.
    Oncogene. 2017;36:5852-5860.
    PubMed     Text format     Abstract available


  27. SPOLVERINI A, Fuchs G, Bublik DR, Oren M, et al
    let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
    Oncogene. 2017;36:5819-5828.
    PubMed     Text format     Abstract available


  28. CHHABRA Y, Wong HY, Nikolajsen LF, Steinocher H, et al
    A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  29. KATO T, Sato T, Yokoi K, Sekido Y, et al
    E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells.
    Oncogene. 2017;36:5522-5531.
    PubMed     Text format     Abstract available


  30. ZHANG Y, Hu Y, Wang JL, Yao H, et al
    Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp.
    Oncogene. 2017;36:5473-5483.
    PubMed     Text format     Abstract available


  31. ROWSON-HODEL AR, Wald JH, Hatakeyama J, O'Neal WK, et al
    Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  32. KIM M, Jang K, Miller P, Picon-Ruiz M, et al
    VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Oncogene. 2017;36:5199-5211.
    PubMed     Text format     Abstract available


  33. CHEN G, Zhang B, Xu H, Sun Y, et al
    Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  34. YAN F, Shen N, Pang J, Zhao N, et al
    A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  35. YURUGI H, Marini F, Weber C, David K, et al
    Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours.
    Oncogene. 2017;36:4778-4789.
    PubMed     Text format     Abstract available


    July 2017
  36. VELMURUGAN KR, Varghese RT, Fonville NC, Garner HR, et al
    High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  37. GARNETT S, Dutchak KL, McDonough RV, Dankort D, et al
    p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  38. UMEDA Y, Hasegawa Y, Otsuka M, Ariki S, et al
    Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  39. WU DW, Lee MC, Hsu NY, Wu TC, et al
    FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-kappaB/Slug-mediated PUMA reduction.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  40. WANG J, Jia Y, Zhao S, Zhang X, et al
    BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  41. NOTO A, De Vitis C, Pisanu ME, Roscilli G, et al
    Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  42. JEN J, Lin LL, Lo FY, Chen HT, et al
    Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  43. FENG J, Yang H, Zhang Y, Wei H, et al
    Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells.
    Oncogene. 2017 Jun 12. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  44. SZCZEPNY A, Rogers S, Jayasekara WSN, Park K, et al
    The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  45. LIAO SY, Chiang CW, Hsu CH, Chen YT, et al
    CK1delta/GSK3beta/FBXW7alpha axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  46. LI H, Xiao N, Wang Y, Wang R, et al
    Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKIgamma.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  47. WANG Q, Ma J, Lu Y, Zhang S, et al
    CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  48. CHOI EJ, Jung BJ, Lee SH, Yoo HS, et al
    A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  49. HSU YL, Hung JY, Chang WA, Lin YS, et al
    Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
    Oncogene. 2017 Apr 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  50. AMBROGIO C, Barbacid M, Santamaria D
    In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma.
    Oncogene. 2017;36:2309-2318.
    PubMed     Text format     Abstract available


  51. LU W, Cheng F, Yan W, Li X, et al
    Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  52. OHM AM, Tan AC, Heasley LE, Reyland ME, et al
    Co-dependency of PKCdelta and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  53. JEN J, Lin LL, Lo FY, Chen HT, et al
    Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format    


  54. NOTO A, De Vitis C, Pisanu ME, Roscilli G, et al
    Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  55. SHAKYA R, Tarulli GA, Sheng L, Lokman NA, et al
    Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: